Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
We’re pleased to announce the MHRA has given notice of validation of our MAA for HMTM, a 4 mg oral tablet for the treatment of mild cognitive impairment (MCI-AD) and mild to moderate Alzheimer’s disease. We look forward to sharing further updates.
Validation means confirmation by. examination and provision of objective. evidence that the particular requirements. for a specific intended use can be. consistently fulfilled
this is from FDA website. means should be approving dy.
